Acupuncture for treating mild to moderate Crohn's disease
Official title: Effect of Acupuncture on Crohn's Disease Via the Regulation of Trp-kyn Metabolism in Brain-gut Axis
Run by Shanghai Institute of Acupuncture, Moxibustion and Meridian · NCT04187820 · Data updated 2026-11-12
This study is testing whether acupuncture can help people with mild to moderate Crohn's disease feel better by looking at their symptoms and brain activity.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years to 70 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Shanghai Institute of Acupuncture, Moxibustion and Meridian Academic / other |
| Drugs / interventions | methotrexate, prednisone |
| Locations | 2 sites (Shanghai, Shanghai Municipality and 1 other locations) |
| Status | Recruiting |
| Started | June 1, 2019 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | May 14, 2025 |
| Trial ID | NCT04187820 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 16-70 with mild to moderate active Crohn's disease who have not responded to or cannot tolerate standard medications.
✕Probably not a fit
Patients with severe Crohn's disease, serious organic diseases, or those currently pregnant or lactating may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of acupuncture on patients with mild to moderate active Crohn's disease. It aims to evaluate how acupuncture influences symptoms of the disease, brain function activity, and the metabolism of tryptophan-kynurenine. The study will also identify brain image markers associated with the therapeutic effects of acupuncture in this patient population. Participants will receive acupuncture treatment while their clinical outcomes and biological markers will be closely monitored.
Why it matters
Potential benefit: If successful, this treatment could provide a non-pharmacological option for managing symptoms of Crohn's disease.
How similar studies have gone: Previous studies have shown promising results for acupuncture in managing symptoms of inflammatory bowel diseases, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. aged 16-70; 2. patients with mild or moderate active disease (150 ≤ CDAI \< 450); 3. patients who are not responsive, intolerant, dependent or refused to use at least mesalazine, glucocorticoid, immunomodulator (azathioprine, methotrexate), anti TNF alpha preparation; 4. patients were not taking medication or were only taking one or more of the following drugs: \[prednisone ≤15mg/d, azathioprine (≤1mg/kg/d), methotrexate (≤15mg/w) or mesalazine (≤4g/d)\] and prednisone was used for at least 1 month, while azathioprine, methotrexate or mesalazine was used for at least 3 months; 5. those who did not use anti-TNF alpha and other agents within 3 months before entering the study; 6. those who have never experienced acupuncture; 7. patients signing informed consent. Exclusion Criteria: 1. patients who are recently pregnant or in pregnancy or lactation; 2. patients with serious organic diseases; 3. patients diagnosed as psychosis; 4. patients who take antibiotics, probiotics, traditional Chinese medicine and other drugs at the same time, or who suffer from multiple diseases and need to take other drugs for a long time, and may affect the observation of the efficacy of this trial; 5. severe skin diseases (such as erythema nodosum, pyoderma gangrenosum, etc.), eye diseases (such as iritis, uveitis, etc.), thromboembolic diseases and other serious extraintestinal manifestations; 6. there are serious intestinal fistula, abdominal abscess, intestinal stenosis and obstruction, perianal abscess, gastrointestinal hemorrhage, intestinal perforation and other complications; 7. patients with short bowel syndrome who have undergone abdominal or gastrointestinal surgery in the past half a year; 8. there are skin diseases or defects in the selected area of acupuncture and moxibustion that cannot be performed.
Where it's running
-
Shanghai Research Institute of Acupuncture and Meridian
Shanghai, Shanghai Municipality, China Recruiting -
Guona Li
Shanghai, China Recruiting
Study contacts
- Study coordinator: Chunhui Bao, MD, PhD
- Email: baochunhui789@126.com
- Phone: +862164395973
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intestinal ultrasound-guided management for inflammatory bowel disease
This study tests if adding point-of-care intestinal ultrasound at every visit changes treatment decisions for adults with Crohn’s disease or ulcerative colitis undergoing disease assessment.
-
Self-management program to improve health in inflammatory bowel disease
A digital self-management program is being tested to see if it helps people with inflammatory bowel disease feel better and manage their symptoms alongside standard care.
-
Lower GI imaging with a tethered camera capsule
This test tries a small camera capsule on a string that takes pictures of the lower gut without sedation for adults who are healthy or who have Lynch syndrome, Crohn's disease, or other inflammatory bowel diseases.
-
COMPARE — Newer IBD treatments in children
This project compares the safety and effectiveness of newer IBD medicines for children with Crohn's disease or ulcerative colitis who did not respond to anti‑TNF treatment.
-
Wireless thermal capsule to detect gastrointestinal temperature changes
This study tests a swallowable wireless thermal capsule to see if it can collect temperature data from the GI tract in healthy adults.
-
Examining the link between polyamine levels and inflammatory bowel disease progression
This study is trying to see if measuring certain substances in the body can help predict how inflammatory bowel diseases like Ulcerative Colitis and Crohn's Disease will progress in patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.